A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials-Reference-Cited by-同舟云学术

A comparison of semiparametric approaches to evaluate composite endpoints in heart failure trials

Published:2021-07-30 Issue:26 Volume:40 Page:5702-5724
ISSN:0277-6715
Container-title:Statistics in Medicine
language:en
Short-container-title:Statistics in Medicine

Author:

Toenges Gerrit¹^ORCID,Mütze Tobias²^ORCID,Jahn‐Eimermacher Antje³

Affiliation:

1. Institute of Medical Biostatistics, Epidemiology and Informatics University Medical Center of the Johannes Gutenberg University Mainz Mainz Germany

2. Statistical Methodology Novartis Pharma AG Basel Switzerland

3. Department of Mathematics and Natural Sciences Darmstadt University of Applied Sciences Darmstadt Germany

Publisher

Wiley

Subject

Statistics and Probability,Epidemiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/sim.9149

Reference46 articles.

1. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials

2. Clinical outcome endpoints in heart failure trials: a European Society of Cardiology Heart Failure Association consensus document

3. Development and Evolution of a Hierarchical Clinical Composite End Point for the Evaluation of Drugs and Devices for Acute and Chronic Heart Failure

4. EMA's Committee for Medicinal Products for Human Use (CHMP) Guideline on multiplicity issues in clinical trials;2017.https://www.ema.europa.eu/en/documents/scientific‐guideline/draft‐guide%line‐multiplicity‐issues‐clinical‐trials_en.pdf. Accessed June 23 2020.

5. FDA's Office of Translational Sciences in the Center for Drug Evaluation and Research. Multiple Endpoints in Clinical Trials ‐ Guidance for Industry;2017.https://www.fda.gov/media/102657/download. Accessed June 23 2020.

Cited by 2 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Utilizing shared frailty with the Cox proportional hazards regression: Post discharge survival analysis of CHF patients;Journal of Biomedical Informatics;2023-04

2. Multistate models as a framework for estimand specification in clinical trials of complex processes;Statistics in Medicine;2023-01-31